Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001)
A study to evaluate safety and tolerability of MK6592 in combination with an anti-cancer drug in adult patients with advanced solid tumors.
Advanced Solid Tumors
DRUG: MK6592|DRUG: comparator: docetaxel
Safety and tolerability of MK6592 alone and in combination with docetaxel, 6 Months
Observance of objective tumor responses in patients treated with MK6592 combined with docetaxel, 6 Months
A study to evaluate safety and tolerability of MK6592 in combination with an anti-cancer drug in adult patients with advanced solid tumors.